Active Pharmaceutical Ingredients ( api )

Rather than focus on just whats in innovative process development, we continue to closely monitor the quality, safety and reliability of our generics, APIs and intermediates.We work tirelessly to deliver high quality generics , APIs and intermediates to market quickly and effectively.

As an improvement-led organization paying attention on providing affordable access, we have leveraged our intrinsic strengths in advanced science to develop, manufacture and convey a rich portfolio of small molecules APIs & formulations.

PROSTAGLANDIN
API's CAS
ALPROSTADIL 745-65-3
BIMATOPROST 155206-00-1
CARBOPROST TROMETHAMINE 58551-69-2
DINOPROSTONE 363-24-6
LATANOPROST 130209-82-4
MIFEPRISTONE 84371-65-3
MISOPROSTOL 9122-46-2
TAFULPROST 209860-87-7
TRAVOPROST 157283-68-6

CARDIOVASCULAR
LEVOSIMENDAN 141505-33-1
PITAVASTATIN 147511-69-1
ROSUVASTATIN 147098-10-2

ANITIMETIC
FOSAPREITANT DIMEGLUMINE 265121-04-8
GRANISETRON HCL 107007-99-8

ANTIBIOTIC
GATIFLOXACIN 112811-59-3
PRULIFLOXACIN 123447-62-1

ANTIVIRAL / ANTIRETROVIRAL
DARUNAVIR 206361-99-1
GANCICLOVIR 82410-32-0

BPH
ALFUZION 81403-80-7
DUTASTERIDE 164656-23-9
FINASTERIDE 98319-26-7

OPIOID ANALGESIC
PROPOFOL 2078-54-b
TAPENTADOL 175591-09-0

TYPE || DIABETES
LINAGLIPTIN 668270-12-0

HYPERTENSION
BRINZOLAMIDE 138890-62-7
DORZOLAMIDE 130693-82-2
NEBIVOVOL 99200-09-6

HBV
ADEFOVIR DIPIVOXIL 142340-99-6
ENTECAVIR 142217-69-4

ANTIFUNGAL
POSACONAZOLE 171228-49-2
SERTACONAZOLE 99592-32-2

ONCOLOGY
ABIRATERONE ACETATE 154229-18-2
ANASTROZOLE 120511-73-1
BENDAMUSTINE 16506-27-7
BICALUTAMIDE 90357-06-5
BLEOMYCIN 11056-06-7
CARMUSTINE 154-93-8
CLADRIBINE 4291-63-8
DOCETAXEL 114977-28-5
ERLOTINIB 183321-74-6
FLUDARABINE PHOSPHATE 75607-67-9
IMATINIB 152459-95-5
LETROZOLE 112809-51-5
MELPHALAN 148-82-3
MITOMYCIN 50-07-7
PACLITAXEL 33069-62-4

NSAID
METHYLPREDNISOLONE 83-43.2
NEPAFENAC 78281-72-8

VITAMIN
FOLIC ACID 59-30-3

Note:  Products protected by valid patents are not offered for 'commercial' sale in countries where the sale of such products constitutes patent infringement but are offered solely for uses reasonably related to the development and submission of information under a law regulating the manufacture, use of sale of drugs. it is within the buyer's responsibility and liability to check the patent situation of the product in the imported market(s).